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Abstract 
The molecular mechanisms that cause emphysema are complex but most 
theories suggest that an excess of proteinases is a crucial requirement. I find 
that the excess of neutrophils in Z alpha(1)-antitrypsin mutation individuals 
and the demonstration that polymers cause an influx of neutrophils when 
instilled into murine lungs. Polymers exert their effect directly on neutrophils 
rather than via inflammatory cytokines. I also find that Ox-AT promotes 
release of human monocyte chemoattractant protein-1 (MCP-1) and IL-8 from 
human lung type epithelial cells (A549) and normal human bronchial epithelial 
(NHBE) cells. These findings were supported by the fact that instillation of Ox-
AT into murine lungs resulted in an increase in JE (mouse MCP-1) and 
increased macrophage numbers in the bronchoalveolar lavage fluid. The 
effect of Ox-AT was dependent on NF-kB and activator protein-1 (AP-1)/JNK. 
These demonstrate that both polymer AT and Ox-AT not only reduce the 
antielastase lung protection, but also converts AT into a proinflammatory 
stimulus. More experiments show that mice transgenic for Z-AT develop a 
significant increase in pulmonary polymers after acute CS exposure (P = 
0.001). Oxidation of human plasma Z-AT by CS or N-chlorosuccinimide 
greatly accelerates polymerization (P = 0.004), which could be abrogated by 
antioxidants (P = 0.359 versus Z control). CS accelerates polymerization of Z-
AT by oxidative modification, which, in so doing, further reduces pulmonary 
defense and increases neutrophil influx into the lungs. These novel findings 
provide a molecular explanation for the striking observation of emphysema in 
ZZ homozygotes who smoke and smoking individuals with emphysema 
without AT deficiency. Further work is required to assess whether antioxidant 
therapy may be beneficial in Z-AT-related COPD. 
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Figure 2. Technique  development.  In China and Japan, I only experienced short periods of training in research techniques. However, 
in Bristol and Cambridge Universities, I was intensively trained in most techniques in basic life science research, including some of the 
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Summary 
Chronic Obstructive Pulmonary Disease (COPD) is a chronic inflammatory 
disease, characterized by progressive and largely irreversible airflow limitation 
due to alveolar destruction (emphysema), small airway narrowing, and chronic 
bronchitis. It is one of the leading causes of morbidity and mortality worldwide 
and in the UK, it may affect approximately 1.5 per cent of the population; and 
up to one in eight emergency admissions may be due to COPD, 
corresponding to over one million bed days, with some 24160 people in the 
UK dying as a result of COPD in 2005 (Burden of Lung Disease 2nd Edition, 
British Thoracic Society 2006). 
 
Most cases of COPD are triggered by chronic inhalation of cigarette smoke. 
However, some people do not suffer from COPD even if they smoke for many 
years. COPD cannot be cured, and patients usually live with poor life quality.  
Treatments include giving up smoking, medication and oxygen therapy. 
 
Genetic factors contribute to the development of COPD. In Northern Europe, 
Z-AT homozygotes (342Glu Lys) develop emphysema in their third or forth 
decade. One explanation is AT deficiency because they form inactive 
polymers. However, this cannot explain why bronchoalveolar lavage fluid 
(BALF) from Z-AT homozygotes with emphysema contains more neutrophils 
than BALF from individuals with emphysema and normal AT (M-AT). Inhaling 
pollutants which include smoking (cigarettes, pipes, cigars, etc.) and other 
fumes such as those found in many industrial work environments probably 
also plays a role in an individual’s development of COPD.  
Previously, it has been shown that the polymeric conformer of AT is present in 
BALF from Z-AT homozygotes and that it is a chemoattractant for neutrophils 
in vitro (Parmar JS, 2002). These findings have been confirmed by others 
(Mulgrew AT, 2004). However, it is unknown where the polymers form and if 
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they are chemotactic in vivo. My colleague Dr Carl Atkison†  showed that 
polymers of Z 1-AT are present in the alveolar wall of Z-AT
 homozygotes with 
emphysema, which accounts for 20% of the total AT from lung homogenates. 
These Z-AT individuals also have an excess of neutrophils in the alveolar wall 
compared with M-AT homozygotes. Furthermore, neutrophils and polymeric 
AT co-localize in the alveolar wall (Mahadeva R, 2005). To investigate 
whether there was a direct relationship between polymers of Z-AT and the 
excess neutrophils, polymers of AT were instilled into the lungs of wild-type 
mice (Mahadeva R, 2005). This produced a significant increase in neutrophil 
influx into the lungs compared with instillation of the native protein. 
Examination of the time course demonstrated that the influx of neutrophils was 
closely linked to the presence of polymeric AT. The mechanism of neutrophil 
recruitment in this mouse model was subsequently shown to be a direct 
chemotactic effect rather than stimulation of IL-8 homologues or other CXC 
chemokines.  
Oxidized AT (Ox-AT) promotes release of human monocyte chemoattractant 
protein-1 (MCP-1) and IL-8 from human lung type epithelial cells (A549) and 
normal human bronchial epithelial (NHBE) cells. Native, cleaved, polymeric 
AT and secretory leukoproteinase inhibitor (SLPI) and oxidized conformations 
of cleaved, polymeric AT and SLPI did not have any significant effect on MCP-
1 and IL-8 secretion. These findings were supported by the fact that instillation 
of Ox-AT into murine lungs resulted in an increase in JE (mouse MCP-1) and 
increased macrophage numbers in the bronchoalveolar lavage fluid. The 
effect of Ox-AT was dependent on NF- B and activator protein-1 (AP-1)/JNK. 
These findings have important implications. They demonstrate that the 
oxidation of methionines in AT by oxidants released by cigarette smoke or 
inflammatory cells not only reduces the anti-elastase lung protection, but also 
converts AT into a proinflammatory stimulus. Ox-AT generated in the airway 
                                               
†  My colleagues’ contributions are acknowledged in future text where appropriate by the 
following superscripts: (a) Dr Sam Alam, (b) Dr Jichun Wang, (c) Dr Carl Atkinson, (d) Dr 
Sabina Janciauskiene.  
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interacts directly with epithelial cells to release chemokines IL-8 and MCP-1, 
which in turn attracts macrophages and neutrophils into the airways. The 
release of oxidants by these inflammatory cells oxidizes AT, perpetuating the 
cycle, potentially contributing to the pathogenesis of COPD. Furthermore, this 
demonstrates that molecules such as oxidants, anti-proteinases, and 
chemokines, rather than acting independently, collectively interact to cause 
emphysema (Li Z, 2009). 
To investigate the molecular basis for the interaction between Z-AT and Ox-
AT associated with cigarette smoking, female mice transgenic for normal (M-
AT) or Z-AT on CBA background were exposed to cigarette smoke (CS). 
Transgenic mice for Z-AT developed a significant increase in pulmonary 
polymers following acute CS exposure. Increased levels of neutrophils in CS-
Z lungs were tightly correlated with polymer concentrations. Oxidation of 
human plasma Z-AT by CS or N-chlorosuccinimide greatly accelerated 
polymerization, which could be abrogated by antioxidants. The results 
showed that cigarette smoke accelerated polymerization of Z-AT by oxidative 
modification, which in so doing further reduced pulmonary defense and 
increased neutrophil influx into the lungs. These novel findings provided a 
molecular explanation for the striking observation of premature emphysema in 
ZZ homozygote smokers, and raised the prospect of anti-oxidant therapy in Z-
AT related COPD (Alam S, 2011). 
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 Chapter 1  
Initial characterization of different conformations of AT 
1.1. Research Training 
My initial research training (Fig 1.) began as a medical student in 1993 and 
had an immunological focus, specifically relating to studies on adjuvant 
arthritis at Peking Union Medical College in Beijing. In 2000, I extended my 
immunological training through the study of Sjogren ‘s Syndrome in Japan for 
six months. Then, I moved to Bristol (UK) and spent nearly another 3 years 
studying the role of CD8+ in Type I diabetes. Through development of 
research strategy on cell culture, animal models and finally human samples, 
using biomedical techniques which included ELISA, IHC. Over this period I 
became sufficiently confident to design experiments, write papers, apply for 
grants, and to present my data to my peers at conference. This provided the 
basis for me following my move to Cambridge to develop my research 
interests into inflammatory aspects of oxidative injury in emphysema 
(presented herein) and I believe this has set a solid foundation for the future 
development of my research into new therapies for emphysema (Fig 1 and 
Fig 2). 
1.2. Introduction to 1-Antitrypsin (AT) 
AT is a single-chain glycoprotein consisting of 394 amino acids in the mature 
form and exhibits a number of glycoforms, it is a serine proteinase inhibitor 
produced primarily by hepatocytes, macrophages, and bronchial epithelial 
cells. The normal protein is termed M-AT according to its migration on 
isoelectric focusing. It is the most abundant proteinase inhibitor (serpin) within 
the lung whose main physiological target is neutrophil elastase. It protects 
tissues from enzymes of inflammatory cells, especially elastase, and has a 
reference range in blood of 1.5 - 3.5 gram/liter, but the concentration can rise 
many folds upon acute inflammation (Kushner,1993). The crystal structure of 
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AT is characterized by a dominant β-sheet A, and an exposed reactive centre 
loop (Silverman GA, 2001) (Fig 3A). The inhibitory mechanism of AT relies on 
cleavage of the methionine-serine P1-P1' by neutrophil elastase. This initiates 
a conformational change in AT whereby the elastase molecule is transferred 
to the lower pole of the AT molecule and inactivated (Huntington JA, 2000).  
In addition to acting as an anti-proteinase, AT plays important role in 
modulating inflammation. It may inhibit immune responses, and fibroblast-
proliferation and fibroblast procollagen production thereby contributing to 
repair and matrix production (Dabbagh, 2001), and have antibacterial 
activities (Hadzic, 2006), and also blocks the cytotoxic and stimulatory activity 
of defensins (Hiemstra, 1998). AT also has direct and indirect anti-apoptotic 
properties by inhibiting caspase-3 or NE mediated apoptosis, respectively 
(Petrache, 2006). AT is also involved in calcium-induced activation 
mechanisms; AT inactivates calpain I (μ-calpain), induces a rapid cell 
polarization and random migration of neutrophils 
 
The AT gene is located on chromosome 14q31-32.1, and is co-dominantly 
expressed (Schroeder, 1985; Bull World Health Organ, 1997; Brantly,1988). 
The gene is 12 kb in length and contains seven exons (Ia, b, c and II–V) and 
six introns. Exon I contains the 3’ untranslated promoter sequences: Ia and Ib 
contains the promoter sequence for macrophage-specific, and Ic for 
hepatocyte-specific transcription, respectively. The coding regions (Exons II-V) 
are 1434 base-pairs (bp) in length and the reactive centre is within Exon V 
(Long, 1984). Aside from the promoter elements, there are other regulatory 
sequences including an enhancer element in the 5' and 3' flanking sequences 
of exonic regions of the AT gene. A polymorphism in the 3’ flanking region is 
associated with susceptibility to COPD (Kalsheker, 1987; Morgan, 1992). A 
map of single nucleotide  polymorphisms (SNPs) in the 5' and 3' flanking 
regions showed that among the 15 SNPs, five SNPs increased the risk of 
COPD by 6- to 50-fold (Chappell, 2006). These polymorphisms within 
regulatory sequences are associated with normal basal plasma levels, but can 
result in reduced levels of AT transcription in response to stimulation in vitro, 
which is postulated to relate to the susceptibility to COPD (Henry, 2001; 
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Chappell, 2006). However, this has not been proven in vivo (Mahadeva, 1998; 
de Faria, 2005; Courtney, 2006; Brennan, 2007).  
Over 100 different variants of α1-antitrypsin have been described in various 
populations. The plasma level of the principal AT phenotypes are MM (20-39 
μmol/L), MS (19-35 μmol/L), SS (14-20 μmol/L), MZ (13-23 μmol/L), SZ (9-15 
μmol/L), ZZ (2-8 μmol/L). One in two thousand North Europeans are 
homozygous for the Z (342Glu Lys) variant of AT. This variant accumulates 
in the hepatocyte by a process of loop-sheet polymerization whereby the 
reactive loop of one molecule inserts into β-sheet A of a second and so on to 
form chains of polymers (Fig 3B). Polymerization in the liver is associated with 
cirrhosis, and the accompanying plasma deficiency leaves the lungs exposed 
to neutrophil elastase resulting in premature emphysema (Eriksson S, 1986; 
Perlmutter DH, 2002). 
AT can be cleaved at the reactive center loop resulting in a profound 
conformational rearrangement in which the loop is fully inserted into the A 
sheet of the molecule (Fig 3A). The cleaved species is inactive, has increased 
thermostability, and is more resistant to unfolding with denaturants (Powell LM, 
1992) when compared to the native protein. It is clear that the sequence of 
events involved in proteinase inhibition requires the loop to be mobile and to 
adopt a variety of conformations. Oxidation of the P1 methionine (methionine 
358) or methionine 351 to methionine sulfoxide significantly reduces the ability 
of AT to inhibit neutrophil elastase. Hydrogen peroxide in cigarette smoke and 
N-chloroamines and hypochlorous acid in neutrophils can oxidize and 
inactivate AT (Scott LJ 1999; Taggart C, 2000). AT can exist in vivo in 
different conformational forms; native, reactive center loop-cleaved, oxidized, 
complexed with neutrophil elastase and Z-AT can be found as polymers (Fig 
3A, Fig3B). 
1.3. Chemical modification of 1-Antitrypsin (AT) 
My initial experiments focussed on the preparation and characterization of 
conformations of AT. Native M-AT (N-AT) was purified from human plasma by 
ammonium sulfate fractionation followed by glutathione and anion exchange  
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Serpin Structure 
 
 
 
 
 
 
Figure3A: From left to right: A, native α1AT (Protein Data Bank (PDB) entry 
1QLP); B, latent ATIII (PDB entry 2ANT); C, cleaved α1AT (PDB entry 7API); 
D, Michaelis complex between Serpin 1 (Alaserpin from Manduca sexta) and 
trypsin (PDB entry 1I99(S. Ye, A. Cech, R. Belmares, E. J. Goldsmith, R. 
Bergstrom, D. Corey, and M. Kanost, submitted for publication)); and E, 
covalent complex between α1AT and trypsin (PDB entry1ezx). In all structures 
the A-sheet is in red, the B-sheet is in green, the C-sheet is in yellow, and the 
RSL(RCL) is in purple. The helices are in gray and are labeled on the 
structure of native α1AT. Trypsin is shown as a cyan coil. 
 
 
 
 
 
 
 
 
 
Figure3B: Demonstration of the partially loop-inserted Z AT (red) that opens 
up ß-sheet A (green) to favour insertion of the reactive loop of another 
molecule to form an AT dimer (centre) and polymers (right) (From Mahadeva 
R, 2005).
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Figure 4 Characterization of conformations of α1-antitrypsin (AT). 
A: 12% (wt/vol) SDS-PAGE. Two micrograms of native AT (N-AT, 52KD), 
Staphylococcus aureus V8 protease reactive loop-cleaved AT (Cl-AT), 
oxidized AT (Ox-AT), short-chain polymers (SP-AT), and long-chain AT 
polymers (LP-AT), were loaded onto 12% SDS-PAGE, 7.5% (wt/vol) non-
denaturing PAGE with (B) and without (C) 8 M urea. A showed N-AT, Ox-AT, 
SP-AT, LP-AT are similar molecular weight, except Cl-AT. B and C showed 
different structure among N-AT, SP-AT, and LP-AT. Aggregates are apparent 
in LP-AT. D: 12% (wt/vol) SDS-PAGE demonstrating the difference in N-AT 
and Ox-AT. N-AT could form an SDS-stable complex with human neutrophil 
elastase, unlike Ox-AT. 
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(from page 8) chromatography by Dr Mahadeva. N-AT migrated as a single 
band on 7.5% nondenaturing and 12% SDS-PAGE and showed a normal 
unfolding transition on transverse urea gel PAGE. Its molecular weight is 
52KD (Fig 4A). It was 70–80% active when assessed by titration against 
bovine -chymotrypsin. The native protein was then used to prepare the other 
AT conformations. Reactive loop-cleaved antitrypsin (Cl-AT) was generated 
by incubation with Staphylococcus aureus V8 protease (Sigma, UK) at 37°C 
for 2 h. The protease was then removed by anion exchange chromatography 
using a mono-Q column. This is distinct from the cleaved fragment; in this 
form COOH-terminal segment remains firmly attached to the core of cleaved 
AT. 
Long- and short-chain polymeric AT (LP-AT and SP-AT, respectively) were 
formed by heating native M-AT (2 mg/ml) at 55°C for 40 and 3 h, respectively. 
These polymers are predicted to have the same loop sheet linkage as Z-AT 
polymers, and thus the same tertiary structure. Polymeric AT was assessed 
on 7.5% non-denaturing PAGE with and without 8 M urea (Fig 4B, C). Native, 
cleaved, and polymeric AT, secretory leukocyte protease inhibitor (SLPI) 
(purified recombinant SLPI was obtained from the Dept. of Otolaryngology and 
Head and Neck Surgery, Malmoe University Hospital, Sweden). Material was 
oxidized as follows: Briefly, N-chlorosuccinimide (Sigma, UK) was incubated in 
a 25 M excess to AT in 0.1 M Tris·HCl (pH 8.0) at room temperature for 30 
min. Excess N-chlorosuccinimide was removed and the buffer was exchanged 
with PBS, using a centrifugal microconcentrator (Centricon YM30). Ox-AT was 
tested for the ability to form an SDS-stable complex with neutrophil elastase 
(Calbiochem). Samples of Ox-AT or N-AT were incubated with neutrophil 
elastase at a 2:1 molar ratio for 15 min at 37°C. The reaction was stopped by 
adding SDS sample buffer and boiling. Mixtures were analyzed by 12% SDS-
PAGE and stained with Coomassie blue. Ox-AT was confirmed and 
distinguished from N-AT by its inability to form an SDS-stable complex with 
human neutrophil elastase (Fig 4D).  
The results show that N-AT, Ox-AT, SP-AT, LP-AT are similar molecular 
weights, 52KD in SDS-PAGE, Cl-AT has lower molecular weight. Ox-AT loses 
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elastase binding capacity, compared with N-AT. LP-AT and appears 
aggregated in 7.5% (wt/vol) non-denaturing PAGE with and without 8 M urea. 
Further characteristics of polymeric AT are described in subsequent chapters 
2-7. 
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Chapter 2  
Polymers of Z 1-Antitrypsin has proinflammatory properties 
in a model of emphysema (Mahadeva R, 2005) 
This work was designed to elucidate the role of polymeric AT on the 
pathogenesis of emphysema in Z-AT homozygotes. Emphysema is thought to 
arise mainly from deficiency of the proteinase inhibitor. Instillation of 
proteinases with elastolytic properties into mammalian lungs, and the 
association of genetic deficiency of AT with emphysema together have formed 
a central pillar of the anti-proteinase-proteinase hypothesis of chronic 
obstructive pulmonary disease. There are however many other mechanisms 
and factors that are important in emphysema (Calverley, 2003). Importantly, 
there are several differences between emphysema with normal and sub-
normal levels of AT. The emphysema in Z-AT homozygotes develops earlier 
in life, initially at least predominantly affecting the basal areas and is of the 
panacinar rather than the centriacinar variety. One striking observation is that 
bronchoalveolar lavage fluid (BALF) from Z-AT homozygotes with emphysema 
contains more neutrophils than BALF from individuals with emphysema and 
M-AT (Morrison, 1987). The reasons for this remain unclear, but may in part 
be because of an excess of interleukin-8 or leukotriene B4 in the BALF. 
However, one additional explanation may be the presence of polymers of AT 
in the lungs of Z-AT homozygotes. Preliminary studies indicated that polymers 
of AT can be detected in BALF from Z-AT homozygotes, and, in vitro, 
polymers of AT are chemotactic to neutrophils (Elliott, 1997; Parmar, 2002). 
This observation raised the novel hypothesis that Z-AT undergoes a 
conformational transition to polymers within the lungs that further depletes the 
local anti-proteinase protection. This would transform AT into a 
proinflammatory stimulus, thus possibly exacerbating the lung disease. 
To test the hypothesis, co-localization of Z-AT polymers with neutrophils in the 
alveoli of individuals with Z-AT by immunhistochemstry (IHC) was investigated. 
(I was assisted by my colleaguec, Dr Atkinson). The following work 
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demonstrated that polymers were proinflammatory in cell and mouse models 
of disease.  
2.1 Polymer AT exists in human lung confirmed by ELISA  
Frozen emphysematous lung tissue from five Z-AT and six M-AT individuals 
(samples from lung transplant surgery in Papworth Hospital) were 
homogenized using Tissue Tearor (Biospec Products) in cell lysis buffer 
(CellLytic; Sigma, St. Louis, MO) on ice. The lung homogenates were 
centrifuged and proteinase inhibitor cocktail (Sigma, Poole, UK). The 
supernatants were kept on ice, then immediately assessed with an in-house 
enzyme-linked immunosorbent assay (ELISA) for the detection and 
quantification of total 1-AT and
 for polymers of AT.  
Briefly, immunoplates (Nunc, Denmark) were coated with rabbit anti-human 
AT (Sigma) primary antibody overnight. This antibody detects all 
conformations of AT. Unbound sites were blocked with PBS containing 1% 
(w/v) bovine serum albumin. Lung homogenates and polymer standards were 
added and incubated at room temperature for 1 hour. A goat anti-human AT 
antibody labelled with horseradish peroxidase (Abcam, UK) was added 
followed by the substrate 2, 2'-azino-bis (3-ethybeniazoline-6-sulfonic acid) 
(Chemicon, Temecula, CA). The plate was read at OD 405 nm and the 
concentration of AT in the samples was calculated from the standard curve. 
The concentrations of AT recovered from the M-AT and the Z-AT lungs were 
compared using the Student’s t-test.  
For the quantification of polymers, the above method was followed, only 
differing in that the primary coating antibody used was a monoclonal antibody, 
ATZII (referred to as the anti-polymer antibody) with polymer standards and 
lung homogenates. The latter antibody recognizes polymeric AT and the AT-
elastase complex, but not the cleaved, or native form of AT. Homogenization 
of monomeric Z-AT in cell lysis buffer did not cause the Z-AT to polymerize. 
ELISA for total AT revealed a 2.5-fold increase in the amount of AT recovered 
from M-AT lungs compared to Z-AT lungs. The mean (SD) concentration of 
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AT was 59.6 (7.0) µg/ml and 23.8 (6.9) µg/ml for M-AT and Z-AT lungs, 
respectively (P= 0.007). Polymeric AT was detected in the Z-AT 
emphysematous lung homogenates mean 4.7 (SD 2.6) µg/ml, but not in the 
M-AT lung homogenates. Polymers constituted on average 20% (SD, 8%) of 
the total AT recovered from Z-AT lungs.  
2.2 Polymers are proinflammatory in mouse experiments 
KC and MIP-2 are the murine homologues of human IL-8, main neutrophil and 
T cell chemoattractants. To assess whether the effect of polymeric AT was 
mediated via chemokines, the BALF content for KC and MIP-2 were assessed 
by specific ELISA (R&D Systems, Minneapolis, MN). BALF was collected from 
C57BL/6J 4, 24, and 72 hours after intratracheal instillation of conformers of 
AT into Murine Lungs. Intratracheal instillation is a delicate procedure. The 
most technically difficult step is setting a cannula into the mouse trachea. This 
work was taught to me by Dr Mahadeva as there were problems with other 
staff being unable to master the technique and so I subsequently took charge 
of this procedure for subsequent experiments. 
Instillation of polymeric AT produced a significant neutrophil influx into the 
BALF at 4 hours and 24 hours  after instillation compared with PBS and native 
AT controls; P < 0.01. By 72 hours neutrophil counts had returned to baseline 
(Figure 5A). There was no significant difference in the neutrophil influx after 
instillation of native AT compared with LPS control. Native and polymer 
samples of AT had a contaminating dose of 10 ng/ml of LPS that equates to 
0.8 ng in 40 µl. Instillation of LPS control produced a small increase in 
neutrophil numbers compared with PBS control. To verify these results, 
neutrophil elastase activity was assessed after lysis of cells recovered from 
BALF using a specific substrate for neutrophil elastase-MeOSuc-Ala-Ala-Pro-
Val-AFC. Neutrophil elastase levels were detectable only after polymer 
instillation at 24 hours, but not after intrapulmonary instillation of native AT or  
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Figure 5. a: Graph demonstrating the effect of intratracheal instillation of 
native and polymeric  1-AT on polymorphonuclear leukocyte (PMN) numbers 
in BALF from C57BL/6J mice. *,P < 0.01 for polymeric AT compared with 
native AT. b: C57BL/6J mice were anesthetized and intubated. Native or 
polymeric -AT in 40 µl of PBS was instilled via the intratracheal route. At 4, 24, 
and 72 hours after instillation, BALF was performed and aliquots were 
assessed on a 7.5% (w/v) non-denaturing PAGE followed by Western blot 
analysis for AT using a polyclonal antibody that recognizes all forms of AT. 
Lane 1: Native AT, starting material 0.1 µg; lane 2: polymeric AT, starting 
material 0.1 µg; lane 3: BALF 4 hours after native AT instillation; lane 4: BALF 
4 hours after instillation of polymeric AT; lane 5: BAL fluid 24 hours after 
native AT instillation; lane 6: BAL fluid 24 hours after instillation of polymeric 
AT; lane 7: BALF 72 hours after native AT instillation; lane 8: BALF 72 hours 
after instillation of polymeric AT.  
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PBS. There were no differences in the numbers of alveolar macrophages 
seen compared with controls. 
To assess the relationship between polymers and neutrophil influx, Western 
blot analysis for AT in BALF after instillation of AT was performed on 7.5% 
(w/v) non-denaturing PAGE. Polymers and native AT were detected at similar 
times after instillation. They were both present at 4 and 24 hours after 
instillation with a suggestion that there was more polymeric AT remaining at 
24 hours. Both native and polymeric AT were undetectable at 72 hours (Figure 
5b). Thus, the time course of neutrophil influx paralleled the presence of 
polymers in the BALF. Furthermore, there was no change in the conformation 
of native AT, which did not spontaneously form polymers within the murine 
lung.  
Disappointingly, concentrations of these cytokines were extremely low. There 
was no significant difference between the concentrations of KC and MIP-2 as 
assessed by ELISA of BALF after instillation of either native or polymeric AT, 
P = 0.14 and 0.22, respectively. There was no detectable KC or MIP-2 at 24 
and 72 hours after instillation of native or polymeric AT. Thus, polymer 
instillation in vivo produced a neutrophil influx that did not appear to be related 
to CXC chemokines. In vitro neutrophil chemotaxis experimentsd showed that 
neutrophil recruitment was a direct effect of polymers. In retrospect if I were to 
repeat this experiment again, I would check the KC and MIP-2 expression 
level in the lung by RT-PCR, as the detection sensitivity of the RT-PCR 
technique is much greater than that of ELISA. 
 
On the other hand, the reason for low concentration of cytokines may be that 
the animal models were not sufficiently sensitive to polymers in vivo, However, 
A549 lung epithelial cell line (American Type Culture Collection) proved 
reactive to polymers and selective conformations of AT in vitro and 
subsequently exciting results were obtained (see chapter 3). 
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Chapter 3  
Ox-AT induced production of IL-8 and MCP-1 from 
A549 cells and NHBE cells (Li Z, 2009) 
IL-8 in humans is produced by numerous cell types, particularly monocyte 
/macrophages, epithelial cells, neutrophils, fibroblasts, and endothelial cells. 
This occurs upon infection by bacteria, or stimulation by bacterial products 
(i.e., pathogen-associated molecular patterns), or stimulation by cytokines 
such as IL-1  and TNF- . IL-8
 is mainly active on neutrophils, promoting their 
recruitment and also their strong activation which is characterized by 
activation of the leukotriene pathway, by the release of their granular content 
(i.e., elastase, lactoferrin, and MPO), and their increased adherence to 
endothelial cells, as well as NO activation. IL-8 is also a chemoattractant for 
other cell types such as basophils, T lymphocytes, and NK cells, and also 
enhances permeability of endothelial cells (Singer M, 2004). 
The monocyte chemoattractant protein-1 (MCP-1/ CCL2) is a member of the 
C-C chemokine family, and a potent chemotactic factor for monocytes. 
Human MCP-1 is composed of 76 amino acids and is 13 kDa in size. MCP-1 
is produced by many cell types, including endothelial, fibroblasts, epithelial, 
smooth muscle, mesangial, astrocytic, monocytic and microglial cells. The cell 
surface receptors that bind MCP-1 are CCR2 and CCR49 (Deshmane SL, 
2009). 
Oxidation of the P1 methionine (methionine 358) or methionine 351 to 
methionine sulfoxide significantly reduces the ability of AT to inhibit neutrophil 
elastase. Hydrogen peroxide in cigarette smoke and N-chloroamines and 
hypochlorous acid in neutrophils can oxidize and inactivate AT (Ossanna PJ, 
1986; Scott LJ, 1999; Taggart C, 2000). Thus, the oxidation of AT by cigarette 
smoke or free radicals in vivo could lead to a relative deficiency of elastase 
inhibitors and has been suggested as a mechanism contributing to the 
development of emphysema in M-AT individuals (Gadek JE, 1979). Oxidant-
mediated inactivation of AT has also been suggested as playing a role in other 
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lung diseases such as cystic fibrosis, adult respiratory distress syndrome, and 
bronchiectasis (McElvaney NG, 1991). In this study, the effect of Ox-AT on the 
production of monocyte chemotactic protein-1 (MCP-1) and IL-8 was 
assessed. 
The group of experiments described in sections 3.1-3.3 took nearly three 
years to finish between 2004 and 2007. It was known that cigarette smoke 
extract and chronic exposure of mice to cigarette smoke augmented the 
generation of IL8 (Vassallo, 2008). However, no studies of the effects of the 
different conformers of AT on MCP-1 were apparent in the literature. To clarify 
this omission, I designed the following experiments to test the effect of N-AT, 
Ox-AT, Cl-AT, LP-AT, SP-AT on the production of MCP-1. Another inhibitor 
SLP1 was also tested for comparison. SLPI consists of 107 amino acids 
(11.7 kDa) organized in a duplicated, boomerang-shaped whey acidic protein 
four-disulfide core (WFDC) domain. It is found in various secretory fluids 
including parotid secretions, bronchial, nasal, cervical mucous and seminal 
fluid. SLPI is a potent inhibitor of many proteolytic enzymes including the 
neutrophil proteases, elastase, cathepsin G, chymotrypsin, and trypsin. In 
addition to its antiprotease function, SLPI has an anti-inflammatory function 
through the modulation of nuclear factor- B acting intracellularly, especially in 
macrophages.  
3.1 Ox-AT induced production of IL-8 and MCP-1 from 
A549 cells 
A549 lung epithelial cell line (American Type Culture Collection) was first 
developed in 1972 through the removal and culturing of cancerous lung tissue 
from the explanted tumor of 58-year-old caucausian male. It is hypotriploid 
with a modal chromosome number of 66, which occurs in 24% of cells. It is 
used as an in vitro model for a type II pulmonary epithelial cell model for lung 
disease research (Standiford T J, 1990). The cells were grown in DMEM 
supplemented with 4,500 mg of glucose/l, L-glutamine, NaHCO3, and 
pyridoxine HCL (Sigma), with 5% FCS and 100 units of penicillin and 0.1 
mg/ml of streptomycin (Sigma), at 37°C, 5% carbon dioxide (CO2) until 80% 
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confluent. Cells were then trypsinized, and 1x105 cells/100 µl media/well were 
cultured in 96-well plates overnight. The following morning, the media was 
aspirated and replaced with 100 µl of fresh media for 30 min followed by 
addition of 15 µl of either N-AT, Ox-AT, SLPI, Ox-SLPI, Cl-AT, Ox-Cl-AT, LP-
AT, or Ox-LP-AT to give a final concentration of 0.03, 0.1, or 0.3 mg/ml. TNF  
was used as a positive control, and LPS (0.01 µg/ml) was used as a negative 
control. The cells were cultured for 4, 10, and 24 h. The culture supernatant 
was collected at each time point and levels of IL-8, MCP-1, and TNF  were 
measured by ELISA using human IL-8, MCP-1/CCL2, TNF  DuoSet, 
according to the manufacturer's instructions (R&D Systems). The LPS dose 
was chosen as the conformations of AT had a contaminating dose of less than 
1 ng/ml LPS.  
Ox-AT significantly induced the production of IL-8 in A549 cells in a time- and 
dose-dependent manner (Ox-AT0.1, 24 h, IL-8 (means SE) =424(14) pg/ml vs. 
PBS 24 h,IL-8 =110(8) pg/ml, P = 0.029; Ox-AT 0.3, 10 h, IL-8 =418(26) pg/ml 
vs. PBS 10 h, IL-8 =43(3) pg/ml, P =0.049;Ox-AT 0.3, 24 h, IL-8 =1,168(9) 
pg/ml vs. PBS 24 h, P =0.008); Ox-AT also significantly induced the 
production of MCP-1(Ox-AT 0.03, 24 h, MCP-1 = 8,725(894) pg/ml vs. PBS 
24 h, MCP-1 = 4,225(470) pg/ml, P = 0.041;Ox-AT 0.1, 24 h, MCP-1 = 
9,167(1,229) pg/ml vs. PBS24 h, P = 0.035; Ox-AT 0.3, 4 h, MCP-1 = 
3,925(711)pg/ml vs. PBS 4 h, MCP-1 = 1,900(424) pg/ml, P = 0.044;Ox-AT 
0.3, 10 h, MCP-1 = 8,608(519) pg/ml vs. PBS 10 h,MCP-1 = 3,075(459) pg/ml, 
P = 0.028; Ox-AT 0.3, 24 h,MCP-1 = 14,500(424) pg/ml vs. PBS 24 h, P = 
0.005). MCP-1 and IL-8 can be produced in response to TNF ; therefore, this 
cytokine was also measured in the supernatant. No significant TNF  secretion 
was detected in response to Ox-AT. 
3.2 Ox-AT induced production of MCP-1 from NHBE cells 
To further confirm these findings in A549 adenocarcinoma epithelial cell line, 
normal human bronchial epithelial (NHBE) cells (CC-2540, Lonza) were 
cultured in supplemented DMEM at 37°C and 5% CO2 until
 80% confluent. 
Using a similar experimental procedure to that described in section 3.1. Again, 
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Ox-AT significantly induced MCP-1 and IL-8 production in NHBE cells in a 
time- and dose-dependent manner compared with N-AT (0.3 mg/ml) at 4 and 
24 h. There was no significant increase in MCP-1 production with 0.03 mg/ml 
Ox-AT compared with 0.03 mg/ml N-AT at 4 or 24 h.  
3.3 Only Ox-AT, (no other oxidized proteins) induced 
production of IL-8 and MCP-1 from A549 cells 
To assess whether the effects seen with Ox-AT were specific, or merely a 
function of oxidized proteins in general, SLPI, Cl-AT, and LP-AT were chosen 
for oxidation (see section 1.3.). Oxidised SLPI, Ox-Cl-AT, Ox-LP-AT at final 
concentrations of 0.03, 0.1, or 0.3 mg/ml were added to A549 cells. The 
supernatant was removed at 4, 10, and 24 h and quantified by ELISA. None of 
these oxidized proteins had any significant effect on the production of IL-8 or 
MCP-1a. 
After this paper was submitted, my reviewer suggested that I further assay the 
effects of oxidised SLPI, Ox-Cl-AT, and Ox-LP-AT on the system described 
above. Dr Alam subsequently finished this experiment. I started to practise 
medicine from end of September, 2008. Since then I have only worked in the 
lab in some of weekend. Dr Alam has worked in the lab from May, 2008. 
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Chapter 4  
Signalling pathway for production of IL-8 and MCP-1 
induced by Ox-AT in A549 cellsb  
4.1 Effect of Ox-AT on NF- B p50 activation in A549 cells 
The expression of many of chemokines such as IL-8/CXCL8 and cytokines 
such as TNFα is regulated by transcription factor, NF- B a pleiotropic 
regulator of inflammatory processes. NF- B is in macrophages and epithelial 
cells of COPD patients. Szulkaowski examined the proteosomal degradation 
of NF- B DNA binding activity in the human lung in response to cigarette 
smoking. NF- B DNA binding was significantly increased in healthy smokers 
and current smokers with moderate COPD, compared with healthy non-
smokers (Szulkaowski P, 2006). Analysis of transcription factor binding sites 
occurring in the promoter regions of differentially-expressed genes revealed 
that NF- B sties were overrepresented among those genes that were 
downregulated by smoking (relative to nonsmokers) and upregulated by 
COPD (relative to healthy smokers) (Pierrou S, 2007).These observations, 
taken together, suggest that modulation of NF- B activity may represent a 
potential target in COPD therapy. The effect(s) of Ox-AT on NF- B p50 
activation in A549 cells were therefore examined. 
Nuclear protein extraction was performed according to the manufacturer's 
instructions (Nuclear Extract Kit, Active Motif, Belgium); the protein levels 
were measured using the RC DC protein kit (Bio-Rad). NF- B activation was 
measured by ELISA using the TransAM NF- B kit according to the 
manufacturer's instructions (Active Motif, Belgium). Briefly, in the TransAM 
NF- B kit, an oligonucleotide that contained the NF- B consensus site (5'-
gggattttcc-3') has been immobilized onto a 96-well plate. The active form of 
NF- B can bind to this site. The NF- B active site on nuclear cell extract (4 µg) 
from cultured cells and homogenized lung tissue was detected through use of 
NF- B antibody p50 (1:1,000) followed by addition of a secondary antibody 
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conjugated to HRP (1:1,000). Active NF- B was quantified by reading 
absorbance at 450 nm (model 680, Bio-Rad). The positive control in this case 
were Jurkat cells which express high endogenous NF- B p50 activity.  
 
The results of these experiments showed that Ox-AT increased the activity of 
NF- B significantly in a concentration-dependent manner compared with PBS 
(P = 0.014). N-AT had no effect on the activity of NF- B.  
4.2 Effect of Ox-AT on AP-1 activation in A549 cells 
The activator protein 1 (AP-1) is a transcription factor which is a heterodimeric 
protein composed of proteins belonging to the c-Fos, c-Jun, ATF and JDP 
families. It regulates gene expression in response to a variety of stimuli, 
including cytokines, growth factors, stress, and bacterial and viral infections. 
AP-1 in turn controls a number of cellular processes including differentiation, 
proliferation, and apoptosis (Ameyar M, 2003). AP-1 activation was assessed 
using the TransAM AP-1 c-Jun kit according to the manufacturer's instructions 
(Active Motif), similar to NF- B assay. 
Ox-AT increased the activity of AP-1 significantly in a concentration-
dependent manner compared with PBS (0.03 mg/ml Ox-AT,P = 0.024; 0.1 
mg/ml Ox-AT, P<  0.001; 0.3 mg/ml Ox-AT,P = 0.005). N-AT had no 
significant effect on the activity of AP-1. The positive control was K562 cells 
with high endogenous AP-1 activity. 
4.3 Effect of SP-600125 (JNK inhibitor) on the activation of 
JNK in A549 cells treated with Ox-AT 
C-Jun N-terminal kinases (JNKs), originally identified as kinases that bind and 
phosphorylate c-Jun on Ser63 and Ser73 within its transcriptional activation 
domain, are mitogen-activated protein kinases which are responsive to stress 
stimuli, such as cytokines, ultraviolet irradiation, heat shock, and osmotic 
shock, and are involved in T cell differentiation and apoptosis. JNK, by 
phosphorylation, modifies the activity of numerous proteins that reside at the 
 24 
 
mitochondria or act in the nucleus. This way, JNK activity regulates several 
important cellular functions.  
SP-600125 (10 µM), an inhibitor of JNK, was added to the cell culture media 
of A549 cells 20 min before treatment with 0.3 mg/ml Ox-AT. The stimulated 
cells in a 96-well plate were directly fixed in situ for the JNK assay 1 h after 
treatment with Ox-AT. Antibody to phosphorylated JNK and antibody to total 
JNK (FACE JNK kit, Active Motif) were used separately for the detection of 
activated JNK and total JNK. A standardized JNK level was obtained by 
subtracting from background (PBS) and expressed as optical density (OD) 
450 nm (JNK level)/OD 595 nm (cell number) (model 680, Bio-Rad). 
Ox-AT significantly increased the level of activated JNK (P = 0.001) but had 
no effect on total JNK (P = 0.7). The ability of Ox-AT to induce JNK activation 
was significantly blocked by the JNK inhibitor SP-600125: OD450/OD595 = 
0.049(0.016), P = 0.016 vs. Ox-AT. SP-600125 had no effect on the total level 
of JNK in cells of both PBS group and Ox-AT group (P = 0.109 and 0.171, 
respectively). 
4.4 Effect of inhibitors of NF- B, p38 MAPK, and JNK on 
the induction of IL-8 and MCP-1 in A549 cells treated with 
Ox-AT 
Bay11-7082, an inhibitor of NF- B, SB-203580, an inhibitor of p38 MAPK, and 
SP-600125, an inhibitor of JNK, were dissolved in 10% DMSO and added to 
cells at a final concentration of 10 µM. Previously published reports indicated 
that 10–50 µM inhibitor do not have any significant cytotoxic effects. The 
cytotoxic effect of each inhibitor was also evaluated using A549 cells at 4, 10, 
and 24 h of culture using Trypan blue assay. There was no significant 
cytotoxic effect of any of the inhibitors (10 µM) on cell proliferation.  They were 
separately added to the cell culture media of A549 cells 20 min before 
treatment with 0.3 mg/ml Ox-AT.  
Ox-AT-inducedIL-8 production [IL-8 = 1526.133(270.03)] was significantly 
 25 
 
reduced in the presence of the NF- B inhibitor [Ox-AT + Bay11-7082, IL-8 
=231(33) pg/ml vs. Ox-AT (P = 0.023)] and the JNK inhibitor [Ox-AT + SP-
600125, IL-8 = 311(47) pg/ml vs. Ox-AT (P = 0.027)]. Ox-AT-induced MCP-1 
production [MCP-1 = 11,188(780)] was significantly reduced in the presence 
of the NF- B inhibitor [Ox-AT + Bay11-7082, MCP-1 = 7,502(524) pg/ml vs. 
Ox-AT, P = 0.049] and the JNK inhibitor [Ox-AT + SP-600125, MCP-1 = 
4,658(727) pg/ml vs. Ox-AT, P =0.003]. There was no significant reduction in 
Ox-AT-induced IL-8 and MCP-1 production in the presence of the MAPK 
inhibitor. 
4.5 Effect of inhibitors of NF- B and JNK on Ox-AT-
induced AP-1 and NF- B activity  
To examine whether NF- B and JNK work independently, JNK inhibitor SP-
600125 was used to study Ox-AT-induced AP-1 activity. Ox-AT induced AP-1 
activity in a dose-dependent manner. The Ox-AT-induced AP-1 activity was 
significantly inhibited in the presence of SP-600125 (0.03 mg/ml Ox-AT, P = 
0.007; 0.1 mg/ml Ox-AT, P < 0.001; and 0.3 mg/ml Ox-AT, P = 0.006). 
However, Bay11-7082 had no effect on AP-1 activity. Ox-AT induced NF- B 
activity in a dose-dependent manner. Bay11-7082 significantly inhibited Ox-
AT-induced NF- B activity (0.03 mg/ml Ox-AT, P < 0.001; 0.1 mg/ml Ox-AT, P 
= 0.018; and 0.3 mg/ml Ox-AT, P = 0.007). There was no significant difference 
in NF- B activity after addition of the JNK (AP-1 pathway inhibitor) inhibitor. 
These findings suggest that NF- B and JNK work independently. 
4.6 Relative effect of NF- B and JNK inhibitors on the 
induction of IL-8 and MCP-1 treated with Ox-AT.  
 
To check whether NF- B and JNK work equally, A549 cells (4 x 105cells/well) 
were cultured in a 24-well plate overnight. The following morning, cells were 
incubated in fresh media for 20 min. Cells were pre-incubated for 20 min with 
either Bay11-7082 (10 µM) or SP-600125 (10 µM) or in combination of Bay11-
7082 (10 µM) and SP-600125 (10 µM). Ox-AT (0.3 mg/ml) was added 20 min 
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later. 24 hours cultured supernatant was collected and quantified for IL-8 and 
MCP-1 production, as detailed previously.  
 
Ox-AT-induced IL-8 and MCP-1 production was significantly reduced in the 
presence of SP-600125 (10 µM) alone and Bay11-7082 (10 µM) alone. Ox-
AT-induced IL-8 and MCP-1 production was almost completely abolished in 
the presence of both SP-600125 and Bay11-7082. These data show that the 
combination of both inhibitors (SP-600125 and Bay11-7082) acts additively to 
reduce IL-8 and MCP-1 production.  
 
All these results demonstrated that Ox-AT increased NF- B and AP-1 activity 
and promoted activation of JNK. Furthermore, inhibition of the NF- B and the 
JNK/AP-1 pathways inhibited production of IL-8 and MCP-1. Both pathways 
appear to act independently and both appeared to mediate the effects of Ox-
AT. 
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Chapter 5 
Ox-AT is pro-inflammatory in animal models 
5.1 Intratracheal instillation of N-AT and Ox-AT into murine 
lungs 
After identifying that Ox-AT is pro-inflammatory in cell lines, I sought to further 
confirm the finding in animal models. All experiments were approved by the 
Home Office. Female C57BL/6 mice, 8 weeks of age, were anaesthetized and 
incubated with a nonpyrogenic 22-gauge cannula. Mice received either 40 µl 
of 2 mg/ml of Ox-AT or N-AT diluted in PBS. A separate group of mice 
received 40 µl of PBS alone. After 4, 24, and 72 h, cohorts of C57BL/6J mice 
(at least 6 in each group) were sacrificed. Bronchoalveolar lavage (BAL) was 
performed with eight aliquots of 0.5 ml of PBS. The BAL samples were 
centrifuged, and BAL fluid (supernatant) was aliquoted. Protease inhibitor 
cocktail (Sigma) and PMSF (1 mmol/l) were added, and the samples were 
stored at –80°C until use. The cell pellet was resuspended, and red blood 
cells were lysed in 0.15 mol/l NH4Cl,
 0.01 mol/l KHCO3, and 1 µmol/l disodium 
ethylene diaminetetra acetic acid (pH 7.2) for 30 s followed by a 5-min wash 
(200 g) in 5 ml of PBS. The cell pellet was resuspended in 1 ml of PBS, and 
the total number of cells was quantified by the mean of two hemocytometer 
counts. To determine inflammatory cell types in BAL fluid, cytospins were 
prepared (350 rpm, 3 min, Cytospin 3, Shandon) from the BAL cellular fraction 
and were stained with Hema 3 (Fisher, Pittsburgh, PA). The proportions of 
different inflammatory cells were determined by counting at least 200 cells.  
Frozen whole lung tissue from mice was homogenized using Tissue Tearor 
(Biospec Products) in cell lysis buffer (CelLytic, Sigma) on ice. The lung 
homogenates were centrifuged, and proteinase inhibitor cocktail (Sigma), 
PMSF (1 mmol/l), and 1 and 10 phenanthroline (1 mmol/l) were added to the 
supernatants. The supernatants were kept on ice and immediately assessed 
for the total protein (RC DC protein kit, Bio-Rad). 
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5.2 Effect of intratracheal instillation of Ox-AT and N-AT in 
murine lungs 
Intratracheal instillation of Ox-AT resulted in increased JE (homologue of 
human MCP-1) in the airway and in the lung tissue. In the BAL fluid, 4 h after 
Ox-AT, there was a significant increase in JE/total protein 16.2(3.6) pg/mg vs. 
N-AT 2.9(1.9) pg/mg, P = 0.037. Concentrations of JE had returned to 
baseline by 24 h, and there was no significant difference. 
There was also a significant increase in JE in homogenized lung tissue 4 h 
after instillation of Ox-AT. JE/total protein was 24.7(4.1) pg/mg vs. N-AT 
10.1(2) pg/mg, P = 0.05. After 24-h Ox-AT treatment, there was no significant 
change. 
 
There was a trend towards increased KC production in the airway and in lung 
tissue, which was not statistically significant. In the BAL fluid, after 4 h, Ox-AT 
KC/total protein 11.8(2.1) pg/mg vs. N-AT 7.1(1) pg/mg, P = 0.11; 24 h, Ox-AT 
7.2(1.7) pg/mg vs. N-AT 6.8 (1.5) pg/mg, P = 0.43. In the homogenized lung 
tissue after 4 h, Ox-AT KC/total protein 48.9 (10) pg/mg vs. N-AT 32.5(5.8) 
pg/mg, P = 0.10; 24 h, Ox-AT 24.7(4) pg/mg vs. N-AT 28.2(2.7) pg/mg, P = 
0.31. There was no effect of Ox-AT on secretion of TNF  in BAL fluid or lung 
tissue. 
 
For cells in BALF, intratracheal instillation of Ox-AT was found to significantly 
induce macrophage influx after 24 h; Ox-AT 23.6(2.8) x 104 vs. N-AT 16.3(0.7) 
x 104, P = 0.03. Ox-AT did not have any significant effect on the number of 
neutrophils. 
 
5.3 Effect of Ox-AT on NF- B p50 and AP-1 activity in lung 
tissue  
Following intratracheal instillation of Ox-AT, NF- B was found to be 
significantly increased in lung homogenates in a time-dependent manner 
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compared with PBS (4 h, P = 0.028; 24 h, P = 0.029; and 72 h, P = 0.037). 
Intratracheal N-AT had no significant effect on the activity of NF- B in lung 
homogenates  
 
Intratracheal Ox-AT resulted in a significantly increased activity of AP-1 in lung 
homogenates in a time-dependent manner compared with PBS (4 h, P = 
0.019; 24 h, P = 0.033; and 72 h, P = 0.049). Intratracheal N-AT had no 
significant effect on the activity of AP-1 in lung homogenates. 
 
5.4 Western blot analysis of lung tissue for JNK  
Homogenized lung tissue was electrophoresed on a 12% SDS-PAGE and 
then electroblotted onto nitrocellulose membranes (Schleicher and Schuell, 
Biosciences). The blots were blocked with PBS/T containing 5% nonfat dry 
milk for 1 h at room temperature. Western blot for activated or phosphorylated 
JNK (phospho-JNK) was performed by incubating with a primary antibody, 
phospho-JNK (1 mg/ml, that detects endogenous human, mouse, and rat 
Thr183/Tyr185 of JNK1), and phosphorylated and nonphosphorylated JNK 
(total-JNK, 0.2 mg/ml, R&D Systems) at 1:500 in PBS/T with 5% nonfat dry 
milk for 1 h at room temperature. The blots were washed three times with 
PBS/T and incubated with HRP-conjugated swine anti-rabbit IgG at 1:1,000 
(Dako). The signals were visualized by an enhanced chemiluminescence 
(ECL) system (Amersham). Densitometric semiquantitative analysis of 
Western blot bands was performed using Image Processing and Analysis in 
Java (ImageJ), version 1.41j. The density of each protein band was corrected 
for background and expressed in arbitrary units. Western blot analysis of 
homogenized lung tissue demonstrated that phospho-JNK was induced by 
Ox-AT compared with N-AT at 4 h, 24 h, and 72 h. Densitometric analysis 
using ImageJ softwarea showed that the level of phospho-JNK was 
significantly higher in lung homogenates from Ox-AT-treated mice, peaking at 
24 h compared with lung homogenates from N-AT-treated mice (4 h, P = 
0.031; 24 h, P = 0.012; and 72 h, P = 0.023). There was no significant 
difference between the amount of total JNK detected from lung homogenates 
from Ox-AT- and N-AT-treated mice at 4, 24, and 72 h. 
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The results from animal experiments further confirmed Ox-AT was 
proinflammatory and Ox-AT increased NF- B and AP-1 activity and promoted 
activation of JNK. 
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Chapter 6 
Acute cigarette smoke exposure promoted polymerization of 
Z-AT via the generation of Ox-AT (Alam S, 2011) 
6.1 Cigarette smoke exposure induces polymers of AT and 
increases pulmonary neutrophils in transgenic Z-AT mice 
After identifying that polymerised AT and Ox-AT are proinflammatory, I wished 
to investigate the relationship between them. The susceptibility of Z-AT 
individuals who smoke to develop COPD is in part related to the combination 
of the severe anti-elastase deficiency arising from an absolute and functional 
reduction in neutrophil elastase inhibitory capacity (Stoller, 2005; Ogushi, 
1987), and the independent multiple effects of cigarette smoke on 
inflammatory cells and molecules (Barnes et al., 2003). In order to investigate 
the molecular basis for the interaction of among Z-AT, Ox-AT and cigarette 
smoke, heterozygous mice transgenic for human Z-AT and human M-AT on a 
CBA background (Ali, 1995) was developed. All animals were maintained 
under specific pathogen-free conditions. Cohorts of 6-10 eight to ten week old 
female mice transgenic for M-AT or Z-AT were exposed to 4 cigarettes smoke 
(CS) per day for 5 days as previously described (Hautamaki, 2004) 
The effect of cigarette smoke (CS) exposure on formation of polymers of AT 
was assessed in bronchoalveolar lavage fluid (BALF) and lung homogenates 
(LH’s) of mice transgenic for Z-AT (Z-mice) and M-AT (M-mice). Polymeric AT 
was undetectable in BALF and LH’s from control M and Z and CS exposed M 
mice. However, following acute CS exposure there was a significant amount 
of polymeric AT detected in the BALF of Z-mice (Fig 6). 
 32 
 
 
 
 
 
 
 
 
 
Figure 6 Significant increase in pAT in plasma of CS-Z when compared to 
control Z mice; p=0.002. Polymeric Z-AT was undetectable in the plasma of 
control M and Z or in CS-M mice. *, control vs. CS and **, CS-M vs. CS-Z 
mice.  
Acute CS exposure, as expected, also resulted in a significant increase in 
polymorpholeukocyte numbers in BALF of both M and Z-AT transgenic mice 
compared to controls, p=0.002 for both. However, CS-Z mice had significantly 
more neutrophils in BALF compared to CS-M mice, p=0.043. The role of the 
excess neutrophils in BALF in CS-Z mice was investigated further by 
assessment of free Neutrophil elastase (NE). CS exposure resulted in a 
significant increase in free NE in BALF in CS-Z compared with CS-M mice. 
The amount of pAT in BALF and LH’s strongly correlated with both BALF and 
LH neutrophil numbers; r2=0.93 and 0.88, respectively (Fig 7).  
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Figure 7 Correlation between pAT and neutrophils in BALF (L) and LH (R). 
r2=0.93 for BALF and and 0.88 for LH, respectively. The amount of pAT in 
BALF and LH’s strongly correlated with both BALF and LH neutrophil 
numbers. 
 
6.2 Cigarette smoke extract induces the formation of 
oxidized-polymeric Z AT in Z-AT micea 
It is known that cigarette smoke contains oxidants that can produce oxidized 
AT (Ox-AT) in vitro (Rahman I, 1999). Therefore, it is hypothesized that 
oxidative modification of the Z-AT molecule by cigarette smoke could lead to 
accelerated polymerization of Z-AT.  
 
Acute CS exposure caused production of Ox-AT in the BALF and LH of M-AT 
and Z-AT mice (Fig 8). Interestingly, there was a significantly greater amount 
of Ox-AT detected in CS-Z compared with CS-M mice; BALF, p=<0.001 and 
LH, p=0.029. Acute cigarette smoke exposure also caused significantly 
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increased production of Ox-AT in the plasma of M-AT and Z-AT mice 
compared to control mice, p=0.024 and p=0.002,respectively. 
Figure 8 Cigarette smoke extract significantly increase the amount of Ox-AT 
in BALF and lung homogenates of CS-Z mice when compared to control Z 
mice.  
Although the results of CF exposure promoting polymerization of Z-AT and 
Ox-AT production were exciting, it was difficult to explain their relationship. 
Further experiments were on hold for about one year, until a new term 
“oxidized polymeric AT“, suddenly appeared in the mind. If the hypothesis that 
acute CS exposure promotes polymerization of Z-AT via the generation of Ox-
AT is correct, then the production of oxidized polymeric Z-AT was anticipated. 
 
Therefore, a novel assay to detect these conformers was set upa. Briefly, 96-
well ELISA plates were coated with mouse anti-human Ox-AT overnight at 
4oC. Plates were washed initially with water and blocked with 5% milk in PBS 
for 2 hrs at RT. After standard washes and blocking, the standard ELISA 
protocol for polymeric-AT was followed by 3 washes with PBS/T and 
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subsequently BALF or lung homogenate was loaded onto the plates and 
incubated for 2 hrs at RT. Plates were washed with PBS/T and incubated with 
a monoclonal anti-polymer antibody. Following 3 washes plates were 
incubated with a rabbit anti-mouse immunoglobulin for 1 hr and developed 
with the substrate and quantified by reading absorbance in a microplate 
reader at wavelength 405 nm.  Standards for oxidized-polymeric AT were 
prepared by heating 50 μl Ox-AT (1 mg/ml) in PBS at 65oC for 45 mins, and 
polymerization of Ox- AT was confirmed by 7.5% non-denaturing PAGE.  
 
Oxidized polymers were only detected in CS-Z mice BALF, LH and plasma. 
Whilst there was evidence of the monomeric oxidized species of AT in CS-M 
mice, there was no detectable oxidized-polymer in the BALF, LH or plasma in 
these mice. This is consistent with the in vitro data that M-AT has a much 
slower rate of polymerization than ZAT. The production of oxidized-polymer in 
CS-Z mice was confirmed by Western blot analysis of samples separated on 
7.5% non-denaturing PAGE and 12% SDS-PAGE gels. Oxidized AT was only 
present in the monomeric form in CS-M mice, whereas both oxidized-
polymers and oxidized monomers were clearly seen in CS-Z mice. 
 
6.3 Analysis of the Relationship between Oxidation and 
Polymerization of Z-ATa 
Plasma-purified Z-AT was exposed to CSE to assess for the temporal 
relationship between the oxidized and polymeric conformers. 
CSE rapidly induced oxidation of plasma Z-AT by 24 hours compared with 
control (P = 0.002; Furthermore, CSE resulted in a 10-fold increase in 
polymers of Z-AT by 24 hours when compared with control Z-AT (P = 0.004). 
Production of the oxidized polymeric conformation in CSE Z was also 
increased 10-fold compared with control Z-AT (P = 0.02).  
More detailed analysis of the immediate effect of CS exposure revealed that 
oxidation of Z-AT preceded polymerization of the protein. Oxidation was 
significantly higher when compared with polymerization (P < 0.001) at the 4- 
to 24-hour time period.  
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To assess this further, we incubated plasma-purified Z-AT with the oxidizing 
agent, N-chlorosuccinimide. N-chlorosuccinimide also increased the 
polymerization rate of Z-AT by 3.2-fold compared with control Z-AT at Day 1 
(P = 0.004), thus supporting the concept that oxidation of Z-AT promoted 
polymerization of Z-AT. 
 
6.4 The effect of the anti-oxidant N-acetyl cysteine on CS 
extract induced oxidation and polymerization of Z α1-
antitrypsina 
 
To further confirm that acute CS exposure promoted polymerization of Z-AT 
via the generation of Ox-AT, N-acetyl cysteine (NAC) was used to abolish the 
oxidant capacity of CSE. The results showed a reduction in the polymerization 
rate of Z-AT back to its baseline rate; the rate of polymerization of CSE Z over 
the first 24 hours was 114.4 nmol/hour, compared with 10.3 nmol/h for control 
and 13.3 nmol/h for CSE + NAC + Z-AT; p=0.135 .The addition of N-acetyl 
cysteine also resulted in a significant reduction in the rate of formation of 
oxidized-polymers of Z-AT back to its baseline rate; CSE Z; 40.4 nmol/h 
compared with 7 nmol/h for control and 4.9 nmol/h for CSE + NAC + Z-AT; 
p=0.285 . 
All these experiments show that CS accelerates polymerization of Z-AT by 
oxidative modification, which, in so doing, further reduces pulmonary defense 
and increases neutrophil influx into the lungs.  
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Chapter 7 
Conclusions and future work 
7.1 Conclusions 
COPD is one of the five leading causes of death worldwide (Mannino D M, 
2007). Unfortunately, there is no cure available for COPD. The majority of 
patients with COPD (80%) are cigarette smokers; however, COPD affects 
only 15–25% of smokers. It is assumed that cigarette smoke is also the major 
cause of chronic inflammation of the lungs. This inflammation does not stop 
after cessation of smoking (Teamoto S, 2007). Pathogenesis of COPD 
remains incompletely understood, there were three main theories: protease –
antiprotese imbalance, oxidative–antioxidative imbalance, and inflammation 
(Abboud RT, 2008; Mak JCW, 2008; Roth M, 2008). 
7.1.1. Protease-antiprotease imbalance in severe AT deficiency 
There is strong evidence to support this hypothesis as the main pathogenic 
mechanism in emphysema associated with severe AT deficiency, as AT is the 
main inhibitor of neutrophil elastase. My experimental results showed another 
mechanism leading to a protease-antiprotease imbalance in the lung in 
severe antitrypsin deficiency (piZZ) is that the abnormal Z antitrypsin 
polymerizing in the lung acts as an inflammatory factor, leading to neutrophil 
recruitment in the lung. 
A novel mechanism driving the development and progression of emphysema 
in Z-AT homozygotes has been identified. Cigarette smoke directly 
accelerates polymerization of Z-AT via oxidation of the protein leading to 
further depletion of the neutrophil elastase protection in the lung and 
enhanced neutrophil influx. The data uniquely suggests that rather than the 
major risk factors for COPD namely cigarette smoke and Z-AT deficiency 
having independent additive effects, they directly interact to create an effect 
greater than the sum of the individual risks. Furthermore, these observations 
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link two of the major prevailing hypotheses in COPD namely, oxidants and 
proteinases in Z-AT related emphysema, and this suggests a role for 
antioxidants in the treatment of this group of individuals (Fig 9). 
 
Figure 9. Schematic diagram depicting the role of conformations of AT and 
the interaction with CS in the development of emphysema. 
7.1.2. Protease-antiprotease imbalance in COPD without severe AT 
deficiency  
The importance of oxidative stress in both lungs and systemic circulation is 
well established in COPD (MacNee W, 2005). Sources of oxidative stress 
arise from inflammatory cells, such as neutrophils and macrophages, which 
generate reactive oxygen species (ROS) when activated. Together with 
inhaled ROS and reactive nitrogen species (RNS), which are abundant in 
cigarette smoke, these endogenous oxidants may constitute a major oxidative 
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burden to the lungs. Oxidative stress occurs when the burden of oxidants is 
not well counterbalanced by the antioxidant defence system. 
Hydrogen peroxide in cigarette smoke and N-chloroamines and hypochlorous 
acid in neutrophils can oxidize and inactivate AT. My results showed oxidized 
AT (Ox-AT) promotes release of human monocyte chemoattractant protein-1 
(MCP-1) and IL-8 from human lung type epithelial cells (A549) and normal 
human bronchial epithelia (NHBE) cells. These findings were supported by 
animal experiments. The effect of Ox-AT was dependent on NF- B and 
activator protein-1 (AP-1)/JNK. Ox-AT not only lost its characteristic ability to 
neutralise elastase, but also induced attraction of neutrophils by Il-8 and 
MCP-1 to produce more elastase, leading to proteolysis of lung connective 
tissue and emphysema (Fig 9).  
7.2. Suggestions for future work 
7.2. 1. Novel Inhibitors 
Recently, some progress has been made on inhibition of polymerization. It is 
recognized that polymerization could be prevented by synthetic peptides with 
homology to strand 4a. However, these peptides are large and also anneal to 
M-AT and other members of the serpin superfamily such asα1- antithrombin 
and therefore were not suitable as therapeutic agents. Understanding the 
distinct conformation adopted by the Z-AT protein facilitated the design of a 
shorter six-mer synthetic peptide (Ac-FLEAIG-NH2). This 6-mer peptide 
preferentially bound to Z-AT rather than M-AT and other common circulating 
serpins. However, the specific binding of the 6-mer to pathologic Z-AT renders 
the Z-AT as inactive, and therefore would not address the predisposition of 
Pizz homozygotes to develop emphysema (Mahadeva R, 2002). 
 
A shorter four-mer synthetic peptide, Ac-TTAI-NH2 has been identified that 
specifically anneals to the pathologic Z-AT by my colleagues ( Alam S, 2012). 
The cell studies showed that it entered the ER of the Z-AT cell without any 
cytotoxicity, and was able to abrogate Z-AT polymerization in vivo. It was also 
able to dissociate existing intracellular Z-AT polymers/aggregates. In addition, 
metabolic labeling demonstrated that in a cell model it was able to significantly 
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restore normal secretion of Z-AT. Furthermore it reduced the ER overload 
response as demonstrated by inhibition of PERK-dependant NF- B activity. 
These findings uniquely demonstrate the potential of this strategy for prevent 
of Z-AT polymer formation in the liver, with preservation of inhibitory function 
in the tissues.  
 
From the experimental results presented here, IL-8, MCP-1 production 
induced by OX-AT was dependent on NF-kappa B and activator protein-1 
(AP-1)/JNK. Abolishing the oxidant capacity of CSE by N-acetyl cysteine 
(NAC) resulted in a reduction in the polymerization rate of Z-AT. These 
findings imply anti-oxidant could be used to treat, or possibly prevent 
emphysema. The mouse model could easily be adapted to test this 
hypothesis.  
Imbalance between protease and antiprotease induces emphysema, 
suggesting that AT could be used to treat and prevent emphysema. 
Recombinant alpha 1-antitrypsin is not yet commercially available, but is 
under investigation as a therapy for alpha 1-antitrypsin deficiency. 
Therapeutic concentrates are prepared from the blood plasma of blood 
donors. The US FDA has approved the use of three alpha 1-antitrypsin 
products derived from human plasma: Prolastin, Zemaira, and Aralast. 
However, these products for intravenous augmentation AT therapy can cost 
up to $100,000 per year per patient. They are administered intravenously at a 
dose of 60 mg/kg once a week. Thus, bulk commercial production of 
recombinant alpha 1-antitrypsin currently seems to be a major barrier to this 
approach. 
Poly (D, L lactide-co glycolide) (PLGA) is a biodegradable and biocompatible 
polymer approved for sustained controlled release of peptides and proteins. 
Pirooznia N at al (Pirooznia N, 2012) prepared a wide range of particle size as 
a carrier of protein-loaded nanoparticles to deposit in different parts of the 
respiratory system especially in the deep lung. The lactic acid to glycolic acid 
ratio affects the release profile of α1AT. Hence, PLGA with a 50:50 ratios 
exhibited the ability to release %60 of the drug within 8, but the polymer with a 
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ratio of 75:25 had a continuous and longer release profile. Cytotoxicity studies 
showed that nanoparticles do not affect cell growth and were not toxic to cells. 
α1AT-loaded nanoparticles may be considered as a novel formulation for 
efficient treatment of many pulmonary diseases. 
7.2.2. Aerosol delivery of inhibitors 
Aerosolized-augmented AT therapy is currently under study. This involves 
inhalation of purified human AT into the lungs, so trapping the AT into the 
lower respiratory tract. This method proves more successful than intravenous-
augmented AT therapy because intravenous use of AT results in only 10%-
15% of the AT reaching the lower respiratory tract, whereas 25%-45% of AT 
can reach the lower respiratory tract through inhalation. Ma et al assayed 
levels of Desmosine and isodesmosine (DI), amino acid cross-links in mature 
elastin, in body fluids which indicated degradation of elastin and can be 
measured more specifically by mass spectrometry. Administration by aerosol 
produced statistically significant reductions in levels of DI in BALF(Ma S, 
2012).However, inhaled AT may not reach the elastin fibers in the lung where 
elastase injury actually occurs.  
Spencer et al observed systemic antibody responses to nonhuman protein 
that was present in very low concentrations in a sheep-derived transgenic 
human AAT formulation (Spencer LT, 2005). Strategies to evaluate immune-
mediated toxic effects of preparations of transgenic protein should be 
established to ensure the development of safe and effective therapies. Once 
sufficient quantities of recombinant alpha 1-antitrypsin become available, 
further more study should be done in this area. 
7.2.3. Stem cell therapy 
Finally, stem cells may be used for treatment for end stage emphysema 
patients. Embryonic and adult stem cells have been suggested as possibilities. 
Adult stem cells have traditionally been thought of as having limited 
differentiation ability and to be organ specific. Kim et al found impaired colony-
forming capacity of circulating endothelial progenitor cells in patients with 
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emphysema. this may contribute to the development of emphysema(Kim EK, 
2012).However, a series of exciting reports over the last 5 to 10 years have 
suggested that adult bone marrow-derived stem cells may have more 
plasticity and are able to differentiate into bronchial and alveolar epithelium, 
vascular endothelium, and interstitial cell types, making them prime 
candidates for repair (Loebinger MR, 2007). Inflammatory lipid mediators, like 
leukotriene B4, may control the proliferation of some stem cell populations, 
again perhaps pointing toward a potentially homeostatic role of some 
elements of the inflammatory repertoire (Taraseviciene-Stewart L, 2008). 
Mesenchymal stem cells protect cigarette smoke-damaged lung and 
pulmonary function partly via VEGF-VEGF receptors, suggesting that MSCs 
have a therapeutic potential in emphysematous rats by suppressing the 
inflammatory response, excessive protease expression, and cell apoptosis, as 
well as up-regulating VEGF, VEGF receptor 2, and TGFβ-1(Guan XJ, 2013). 
 
7.2.4. Recent advances in my research 
 
Since publication of my last paper I have already conducted some work on 
stem cells. Human cord blood cells were transfused into C57BL/6 mouse lung 
by intravenous or intratracheal routes. The cord cells persist in the lung for up 
to 5 days. Large amounts of lymphocytes were also found in BAL fluid, 
possibly because of rejection response. In future experiments, SCID mouse 
and emphysema mouse models may be used and the long-term effects will be 
monitored. If these experiments are successful, stem cells may be a 
revolution in the development of new therapies for COPD.  
 
However, as I know, there are a lot of patent limitations for the future research 
or production, from antitrypsin purification using human plasma, expression 
and production from plant, rice, milk, bacteria, yeast, et al to treatment via 
intravenous or aerosolization.  
 
Although the role of alpha antitrypsin in the pathogenesis of COPD is still far 
from being fully understood I feel that my work has made a step towards 
clarification of the mechanism that underpin the pathology of this common 
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disease. I therefore hope in the future to make further contributions that will 
build on the work described in this thesis. 
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